The current stock price of IDXX is 644.61 USD. In the past month the price decreased by -9.51%. In the past year, price increased by 40.2%.
ChartMill assigns a technical rating of 2 / 10 to IDXX. When comparing the yearly performance of all stocks, IDXX is one of the better performing stocks in the market, outperforming 73.94% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to IDXX. IDXX scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months IDXX reported a non-GAAP Earnings per Share(EPS) of 13.07. The EPS increased by 16.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 24.65% | ||
| ROA | 30.34% | ||
| ROE | 65.81% | ||
| Debt/Equity | 0.53 |
22 analysts have analysed IDXX and the average price target is 781.34 USD. This implies a price increase of 21.21% is expected in the next year compared to the current price of 644.61.
For the next year, analysts expect an EPS growth of 13.36% and a revenue growth 8.92% for IDXX
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.33 | 189.676B | ||
| ISRG | INTUITIVE SURGICAL INC | 49.14 | 168.855B | ||
| SYK | STRYKER CORP | 23.7 | 138.597B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.78 | 115.097B | ||
| BDX | BECTON DICKINSON AND CO | 13.98 | 58.942B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.59 | 45.321B | ||
| RMD | RESMED INC | 22.12 | 38.981B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.06 | 37.494B | ||
| DXCM | DEXCOM INC | 27.8 | 27.258B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
IDEXX LABORATORIES INC
One Idexx Drive
Westbrook MAINE 04092 US
CEO: Jonathan J. Mazelsky
Employees: 11000
Phone: 12075560300
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
The current stock price of IDXX is 644.61 USD. The price increased by 0.16% in the last trading session.
IDXX does not pay a dividend.
IDXX has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
22 analysts have analysed IDXX and the average price target is 781.34 USD. This implies a price increase of 21.21% is expected in the next year compared to the current price of 644.61.
The PE ratio for IDEXX LABORATORIES INC (IDXX) is 49.32. This is based on the reported non-GAAP earnings per share of 13.07 and the current share price of 644.61 USD.